Every advancement in women’s healthcare begins with research. Clinical trials are carefully designed studies that help physicians discover new ways to prevent, diagnose, and treat medical conditions while improving the standard of care for future generations.
At Arizona Women’s Research, clinical trials offer eligible participants access to innovative therapies and treatments that are not yet widely available. Every study is conducted under strict medical and ethical guidelines, with patient safety, privacy, and informed consent at the center of every step.
Choosing to participate in a clinical trial is a personal decision. Our experienced research team is here to answer your questions, explain your options, and help you determine whether a study is right for you. Participation is always voluntary, and you may leave a study at any time.
Whether you are exploring new treatment options or simply want to learn more about medical research, we’re committed to making the process transparent, supportive, and easy to understand.
Below are answers to some of the most common questions about clinical trials, research studies, eligibility, safety, and what you can expect if you choose to participate.
The purpose of this study is to look at how a prenatal screening test is used during pregnancy and how its results help guide pregnancy care. The test uses a single blood draw from the pregnant person to screen for both severe inherited (recessive) conditions and chromosomal differences such as Down syndrome, without needing separate samples from a partner. Pregnant individuals at least 10 weeks along, carrying a single baby or twins, and willing to have this screening done are needed at this stage of research.
1 blood draw, plus 1 optional cheek (buccal) swab of the baby after birth.
The purpose of this study is to collect blood samples to help validate a screening test for preeclampsia, a serious blood-pressure condition of pregnancy. The goal is to improve early detection so care can begin sooner.
3 blood draws total, one per trimester.
The purpose of this study is to help develop and validate a non-invasive prenatal test that can screen for single-gene inherited conditions, using a simple blood draw instead of more invasive procedures. Pregnant individuals at least 9 weeks along are needed at this stage of research.
1 blood draw, plus 1 cheek (buccal) swab of the baby after birth.
The purpose of this study is to collect blood samples to test, improve, and further develop a suite of cell-free DNA screening tests used during pregnancy. Pregnant individuals carrying a single baby, between 10 and 16 weeks along, who have had an abnormal prenatal screening (NIPT) are needed at this stage of research.
1 blood draw.
The purpose of this study is to compare a fetal monitoring device against standard-of-care monitoring during in-clinic sessions, as part of an FDA submission for the device. Pregnant individuals carrying a single baby and at least 32 weeks along are needed at this stage of research.
At least 1 in-clinic monitoring session.
Some studies offer compensation for time and participation. Compensation varies by study.
Not always. Coverage requirements depend on the specific trial.
In many cases, yes. Our research team works alongside your healthcare providers whenever appropriate.
Each study is different. Some trials compare treatments, while others evaluate new therapies or approaches.
No. Requesting information does not obligate you to join a study.
Every study is different. In many cases, clinical trials work alongside your current care plan, while some may involve new therapies or treatment approaches. Our team will explain all details before participation.
Study timelines vary depending on the type of research. Some trials may last a few weeks, while others continue for several months or longer.
Participation is always voluntary. You may leave a clinical trial at any time for any reason.
No. Clinical trials can involve a wide range of health topics, including preventive care, wellness, reproductive health, pregnancy care, chronic conditions, and new treatment options.
Yes. Clinical trials follow strict privacy and confidentiality regulations to help protect your medical information and personal data.
